2+ day, 3+ hour ago   (301+ words) Sept 11 (Reuters) – AstraZeneca’s breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company said ​on Friday, a week after the treatment received U.S. ‌approval. U.S.-listed shares of AstraZeneca…...

2+ day, 10+ hour ago   (264+ words) Sept 10 (Reuters) – The first horse in the United States to be infected with New World screwworm has been detected in southern Texas ​near the Mexican border, data from the U.S. ‌Department of Agriculture showed. The case of the flesh-eating…...

3+ day, 3+ hour ago   (109+ words) kfgo.com Novo Nordisk says Wegovy approved in China for liver disease MASH STOCKHOLM, Sept 10 (Reuters) – Denmark’s Novo Nordisk said ​on Thursday its blockbuster weight-loss drug Wegovy had been approved in China ​as ⁠the first ⁠GLP-1 RA class of drugs…...

4+ day, 17+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

5+ day, 35+ min ago   (351+ words) MINNESOTA (MinnPost) – After more than a year of contract negotiations and on the heels of a one-day strike in early July, Allina Health hospice nurses are set to strike for one week starting September 11 after union members said the hospital…...

5+ day, 6+ hour ago   (652+ words) NEW DELHI, Sept 8 (Reuters) – India is witnessing an unprecedented food safety crackdown, with regulators forcing many local eateries and branded restaurants to suspend operations, while a push for front-of-pack warning labels has rattled the country’s more than $100 billion packaged food…...

5+ day, 23+ hour ago   (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its ​experimental cardiovascular drug ziltivekimab, further ‌denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...

6+ day, 3+ hour ago   (145+ words) LONDON, Sept 7 (Reuters) – Shares of Novartis fell 3.3% on Monday morning after ​its cholesterol drug failed ‌in a closely watched study, casting fresh doubt on the therapeutic approach and raising the ‌stakes ​for the ⁠Swiss drugmaker’s upcoming ⁠data for a gene…...

1+ week, 3+ day ago   (171+ words) Sept 2 (Reuters) – AI company Owkin said on Wednesday it has signed a licensing deal ​with Germany’s Boehringer Ingelheim, ‌giving the drugmaker access to its AI research platform and patient data to speed up discovery of drugs for cancer ‌and ​immunity-related…...

1+ week, 3+ day ago   (516+ words) By Emma Rumney and Jonathan Stempel LONDON/NEW YORK, Sept 2 (Reuters) – Marlboro-maker Altria on Wednesday sued the U.S. Food and Drug Administration, seeking to force the agency to overhaul a product review process that tobacco companies say has stifled their…...